Liver vitamin D receptor, CYP2R1, and CYP27A1 expression: relationship with liver histology and vitamin D3 levels in patients with nonalcoholic steatohepatitis or hepatitis C virus.
about
The Role of Vitamins in the Pathogenesis of Non-alcoholic Fatty Liver DiseaseVitamin D and chronic hepatitis C: effects on success rate and prevention of side effects associated with pegylated interferon-α and ribavirinDietary habits and behaviors associated with nonalcoholic fatty liver diseaseMetabolic aspects of adult patients with nonalcoholic fatty liver diseaseVitamin D: a new player in non-alcoholic fatty liver disease?Non-alcoholic fatty liver disease: an emerging driving force in chronic kidney disease.Vitamin D3 Loading Is Superior to Conventional Supplementation After Weight Loss Surgery in Vitamin D-Deficient Morbidly Obese Patients: a Double-Blind Randomized Placebo-Controlled Trial.Low Levels of 25-Hydroxy Vitamin D are Independently Associated with the Risk of Bacterial Infection in Cirrhotic Patients.Clinical application of transcriptional activators of bile salt transporters.Relationship between adipose tissue dysfunction, vitamin D deficiency and the pathogenesis of non-alcoholic fatty liver disease.Relationship between Nonalcoholic Fatty Liver Disease and Vitamin D Nutritional Status in Extreme Obesity.Modern approach to the clinical management of non-alcoholic fatty liver diseaseMeta-analysis: vitamin D and non-alcoholic fatty liver disease.Association between vitamin D and non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: results from a meta-analysis.Vitamin D deficiency in chronic liver disease.1(OH) vitamin D3 supplementation improves the sensitivity of the immune-response during Peg-IFN/RBV therapy in chronic hepatitis C patients-case controlled trial.Serum concentrations of 25-hydroxyvitamin D and immunoglobulins in an older Swiss cohort: results of the Senior Labor StudyVitamin D status and viral response to therapy in hepatitis C infected children.Recent advances in dietary supplementation, in treating non-alcoholic fatty liver disease.Relationship of vitamin D status with advanced liver fibrosis and response to hepatitis C virus therapy: a meta-analysis.Can skin exposure to sunlight prevent liver inflammation?Vitamin D Levels Are Inversely Associated with Liver Fat Content and Risk of Non-Alcoholic Fatty Liver Disease in a Chinese Middle-Aged and Elderly Population: The Shanghai Changfeng StudyNo effects of oral vitamin D supplementation on non-alcoholic fatty liver disease in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial.Sustained suppression of viral replication in improving vitamin D serum concentrations in patients with chronic hepatitis BNuclear receptors as drug targets in cholestatic liver diseases.Low 25-hydroxyvitamin D level is independently associated with non-alcoholic fatty liver disease.Correlation between vitamin D levels and apoptosis in geriatric patients infected with hepatitis C virus genotype 4.Vitamin D3: A Role in Dopamine Circuit Regulation, Diet-Induced Obesity, and Drug ConsumptionHigh fat diet enriched with saturated, but not monounsaturated fatty acids adversely affects femur, and both diets increase calcium absorption in older female mice.Immunogenomics reveal molecular circuits of diclofenac induced liver injury in miceThe association between serological and dietary vitamin D levels and hepatitis C-related liver disease risk differs in African American and white malesAssessment of Vitamin D status in a group of Egyptian children with non alcoholic fatty liver disease (multicenter study).Vitamin D serum level is associated with Child-Pugh score and metabolic enzyme imbalances, but not viral load in chronic hepatitis B patients.Implications of prognostic variables in the assessment of autoimmunity in hepatitis C patients receiving interferon therapy.Could vitamin d supplementation benefit patients with chronic liver disease?Vitamin D is Not Associated With Severity in NAFLD: Results of a Paired Clinical and Gene Expression Profile Analysis.Decreased Expression of Vitamin D Receptor Affects an Immune Response in Primary Biliary Cholangitis via the VDR-miRNA155-SOCS1 Pathway.Nonalcoholic fatty liver disease and decreased bone mineral density: is there a link?Pathophysiological mechanisms and therapeutic potentials of macrophages in non-alcoholic steatohepatitis.The Association between Vitamin D Insufficiency and Nonalcoholic Fatty Liver Disease: A Population-Based Study.
P2860
Q26752762-4838D7C5-192F-4C9B-99B8-B93D5CA8A6BCQ26784321-0F84769C-1F1F-4627-87C4-42D2C3C0B3F7Q26830594-34C8A531-A833-4F35-861B-153A1BEBE722Q28067490-B9B7C56A-9A66-4611-8A5A-8E93AF29B6E6Q28081391-6606FC15-02B4-4AA4-833D-603EE9D0BAD4Q30235846-2CFAEA90-1927-4FF0-AB41-4F2813C4AE6AQ33599951-6CC32D86-FF55-49B9-8F82-246CD3FEA185Q33701184-B5237A17-A034-466B-939D-841B2AB20E92Q33709930-99A6259F-897D-4D92-AFA9-7D608BB9E043Q33719929-AECF1ED0-41F2-43C2-B59D-8FF3BC2D5288Q33823038-1F73D469-ED4D-4E73-BB7A-349771BC5568Q33886923-8F43A398-5BB3-4A36-88FC-EA888500D3BBQ34352252-4EF3EB53-36D5-410D-8E70-79C43387290BQ34509148-1CB1B4A8-FD06-4695-97F9-120D75AD9A5EQ34728285-BBF34AD2-DC3F-495C-9F0F-0BF66C661331Q34744383-4A35206C-A43A-471D-98B7-72FD5D48F0A2Q34884547-438E4872-741D-4988-9767-F33E4173588EQ35012136-7CC494DC-2584-4E8D-BF2F-2C6DBD5D6FB6Q35127037-8D165BB8-7E90-4DFF-8AEA-B2C0721C7439Q35197174-AE8D388B-CA36-4394-A5EA-D2689BFD5F6DQ35658038-98242E14-88EC-4F5C-B3AB-2618667B53FDQ36047914-5EF4E51F-7A45-43DC-B5AD-3BB0A39EDB51Q36063593-1E2564D6-5FAE-416A-A67D-046B969F3AFDQ36187521-ABAA084B-7F7B-4013-A3FE-A1E799AFC499Q36786270-3D772EEE-28F7-45D5-966E-F55809FBC4B3Q36859567-88128599-36E8-4F7A-856E-92F3A4C6603AQ36888680-CEAE1CA4-7001-4E77-AE97-6FFCAA5DD857Q36922890-4DB07F56-1903-4529-BEEF-CBC5F3097592Q37033754-E2F81C0A-E3F0-4C0F-A193-8013E7A16D1EQ37046776-CD07E8E2-4562-4D48-8B47-80DCEAAAD151Q37091418-01D9C1BE-7002-4D92-AC8A-16A0667B3165Q37192191-880D5C13-71B2-4167-AAFA-EC723F509CC9Q37327874-E116A1FD-E52C-4F16-8A11-B5E49DDB0464Q37608269-2307BCD6-509C-4B41-B46F-4A35D9E200DCQ37663928-3DE2EB1F-CCC2-4CF4-8129-B2937E8C266AQ37673981-55A549D4-777C-49AC-8D5C-5792ACC65E46Q37690726-C6912E69-78B4-42D9-AE08-15E2EE2DB5B9Q38500120-C44C03C8-E078-4842-9D4E-F942CEA95921Q38648556-A4EE681C-A4D6-4761-A9F0-04173473EBF1Q38651073-96A63265-95FF-407D-8E33-982E09B902E7
P2860
Liver vitamin D receptor, CYP2R1, and CYP27A1 expression: relationship with liver histology and vitamin D3 levels in patients with nonalcoholic steatohepatitis or hepatitis C virus.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Liver vitamin D receptor, CYP2 ...... epatitis or hepatitis C virus.
@en
Liver vitamin D receptor, CYP2 ...... epatitis or hepatitis C virus.
@nl
type
label
Liver vitamin D receptor, CYP2 ...... epatitis or hepatitis C virus.
@en
Liver vitamin D receptor, CYP2 ...... epatitis or hepatitis C virus.
@nl
prefLabel
Liver vitamin D receptor, CYP2 ...... epatitis or hepatitis C virus.
@en
Liver vitamin D receptor, CYP2 ...... epatitis or hepatitis C virus.
@nl
P2093
P2860
P50
P921
P356
P1433
P1476
Liver vitamin D receptor, CYP2 ...... epatitis or hepatitis C virus.
@en
P2093
Antonio Fraioli
Francesco Angelico
Frida Leonetti
Giancarlo Labbadia
Ilaria Barchetta
P2860
P304
P356
10.1002/HEP.25930
P407
P50
P577
2012-12-01T00:00:00Z